Skip to content
Screener

Harmony Biosciences Holdings, Inc. HRMY Other income, net (Note 6)

Other income, net (Note 6) at other companies

Alkermes logo
AlkermesALKS
$352K-54.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$18K-35.7%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$653K-59.3%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$647K+8.9%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$13.18M+167%
RFL
Rafael Holdings, Inc.RFL
-$25K-116%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$2.26B+13.1%
Enterprise value$1.83B+12.9%
P/E15.5×+4.5×
P/S2.5×-0.1×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 8:16 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056720
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
General and administrative32,50731,243
Total operating expenses133,58496,494
Operating income37,29156,245
Other expense, net(127)(276)
Interest expense(3,234)(3,836)
Interest income5,7575,044
Income before income taxes39,68757,177
Income tax expense(7,199)(11,617)

Item 1. Financial Statements

FAQ

What is Harmony Biosciences Holdings, Inc.'s other income, net (note 6)?
Harmony Biosciences Holdings, Inc. (HRMY) reported other income, net (note 6) of -$127K in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s other income, net (note 6) changed year-over-year?
Harmony Biosciences Holdings, Inc.'s other income, net (note 6) increased by 54.0% year-over-year, from -$276K to -$127K.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s other income, net (note 6)?
Over 3 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s other income, net (note 6) has grown at a 249.0% compound annual growth rate (CAGR), from $16K to -$680K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Harmony Biosciences Holdings, Inc.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude